GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (NYSE:BDX) » Definitions » Gross Profit

BDX (Becton Dickinson) Gross Profit : $9,333 Mil (TTM As of Dec. 2024)


View and export this data going back to 1963. Start your Free Trial

What is Becton Dickinson Gross Profit?

Becton Dickinson's gross profit for the three months ended in Dec. 2024 was $2,235 Mil. Becton Dickinson's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $9,333 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Becton Dickinson's gross profit for the three months ended in Dec. 2024 was $2,235 Mil. Becton Dickinson's Revenue for the three months ended in Dec. 2024 was $5,168 Mil. Therefore, Becton Dickinson's Gross Margin % for the quarter that ended in Dec. 2024 was 43.25%.

Becton Dickinson had a gross margin of 43.25% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Becton Dickinson was 49.33%. The lowest was 42.17%. And the median was 45.35%.


Becton Dickinson Gross Profit Historical Data

The historical data trend for Becton Dickinson's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Gross Profit Chart

Becton Dickinson Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,798.00 8,631.00 8,477.00 8,170.00 9,125.00

Becton Dickinson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,027.00 2,304.00 2,307.00 2,487.00 2,235.00

Competitive Comparison of Becton Dickinson's Gross Profit

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Gross Profit distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Gross Profit falls into.


;
;

Becton Dickinson Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Becton Dickinson's Gross Profit for the fiscal year that ended in Sep. 2024 is calculated as

Gross Profit (A: Sep. 2024 )=Revenue - Cost of Goods Sold
=20178 - 11053
=9,125

Becton Dickinson's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=5168 - 2933
=2,235

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9,333 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Becton Dickinson's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,235 / 5168
=43.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Becton Dickinson  (NYSE:BDX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Becton Dickinson had a gross margin of 43.25% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Becton Dickinson Gross Profit Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Executives
Richard Byrd officer: EVP & President Interventional BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Bertram L Scott director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Jeffrey William Henderson director 7000 CARDINAL PLACE, DUBLIN OH 43017
David Shan officer: EVP, Integrated Supply Chain 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shana Carol Neal officer: Chief People Officer 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA 23116
Michael David Garrison officer: EVP and President Medical BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Roland Goette officer: EVP and President, EMEA BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Thomas J Spoerel officer: VP Controller & Chief Acct Off BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Claire Fraser director C/O BECTON, DICKINSON AND COMPANY, FRANKLIN LAKES NJ 07465
David Hickey officer: EVP & President, Life Sciences BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Joanne Waldstreicher director C/O STRUCTURE THERAPEUTICS INC., 611 GATEWAY BLVD, SUITE 223, SOUTH SAN FRANCISCO CA 94080
Michelle Quinn officer: EVP and Acting General Counsel 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher Delorefice officer: EVP & CFO BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Polen Thomas E Jr officer: Executive Vice President BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Samrat S. Khichi officer: EVP and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873